On July 13, 2018, the Food and Drug Administration issued a voluntary recall of valsartan, which is used to treat high blood pressure. Express Scripts identified 8,400 TRICARE beneficiaries who received the contaminated product through the mail order network. Another 17,200 TRICARE beneficiaries received a potentially contaminated product from retail pharmacies. The Department of Defense sent letters to all beneficiaries who received the product. Compare the information on your prescription bottle with the information in the recall list. If your medicine is included in the recall, contact your pharmacist or physician. For more information, visit the FDA website.
For complete guides on TRICARE programs, visit the Military.com TRICARE section.